Ralph Garippa

2.5k total citations
42 papers, 1.3k citations indexed

About

Ralph Garippa is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Oncology. According to data from OpenAlex, Ralph Garippa has authored 42 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 10 papers in Cellular and Molecular Neuroscience and 8 papers in Oncology. Recurrent topics in Ralph Garippa's work include Neuropeptides and Animal Physiology (8 papers), CRISPR and Genetic Engineering (7 papers) and Receptor Mechanisms and Signaling (7 papers). Ralph Garippa is often cited by papers focused on Neuropeptides and Animal Physiology (8 papers), CRISPR and Genetic Engineering (7 papers) and Receptor Mechanisms and Signaling (7 papers). Ralph Garippa collaborates with scholars based in United States, Switzerland and South Korea. Ralph Garippa's co-authors include David Bolin, Mike O’Donnell, Ann F. Welton, Yifat S. Oren, Tamar Golan‐Lev, Uri Ben‐David, Payal Arora, Gianni Gromo, Martin Graf and Alicia Leikin‐Frenkel and has published in prestigious journals such as Cell, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Ralph Garippa

41 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ralph Garippa United States 21 901 277 277 147 136 42 1.3k
Claus Liebmann Germany 21 952 1.1× 300 1.1× 288 1.0× 165 1.1× 96 0.7× 62 1.5k
Randall P. French United States 18 788 0.9× 133 0.5× 249 0.9× 118 0.8× 117 0.9× 25 1.4k
Xiu-Rong Ren United States 17 1.2k 1.3× 316 1.1× 259 0.9× 123 0.8× 106 0.8× 20 1.5k
Juan Manuel García‐Martínez Spain 13 1.4k 1.5× 230 0.8× 121 0.4× 185 1.3× 139 1.0× 18 1.7k
Patrick E. Burnett United States 11 1.6k 1.8× 348 1.3× 189 0.7× 165 1.1× 348 2.6× 15 1.9k
Luisella Toschi Germany 12 867 1.0× 218 0.8× 241 0.9× 138 0.9× 116 0.9× 25 1.4k
Raymond K. Tong United States 12 1.1k 1.2× 478 1.7× 582 2.1× 200 1.4× 175 1.3× 15 1.7k
Tara J. Dillon United States 16 1.2k 1.3× 381 1.4× 208 0.8× 202 1.4× 266 2.0× 23 1.7k
Maria Kontogiannea Canada 13 853 0.9× 235 0.8× 263 0.9× 140 1.0× 151 1.1× 17 1.3k
Christopher G. Armstrong United Kingdom 16 1.1k 1.2× 157 0.6× 172 0.6× 123 0.8× 205 1.5× 21 1.5k

Countries citing papers authored by Ralph Garippa

Since Specialization
Citations

This map shows the geographic impact of Ralph Garippa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ralph Garippa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ralph Garippa more than expected).

Fields of papers citing papers by Ralph Garippa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ralph Garippa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ralph Garippa. The network helps show where Ralph Garippa may publish in the future.

Co-authorship network of co-authors of Ralph Garippa

This figure shows the co-authorship network connecting the top 25 collaborators of Ralph Garippa. A scholar is included among the top collaborators of Ralph Garippa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ralph Garippa. Ralph Garippa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Nan, Hyunwoo Cho, James O.S. Hackland, et al.. (2025). Genome-wide CRISPR screen identifies Menin and SUZ12 as regulators of human developmental timing. Nature Cell Biology. 27(9). 1411–1421.
2.
Mao, Ninghui, Young Sun Lee, Zeda Zhang, et al.. (2025). Uncoupling of Akt and mTOR signaling drives resistance to Akt inhibition in PTEN loss prostate cancers. Science Advances. 11(6). eadq3802–eadq3802. 5 indexed citations
3.
Minotti, Andrew P., Polina Oberst, Zeping Zhao, et al.. (2024). Combined small-molecule treatment accelerates maturation of human pluripotent stem cell-derived neurons. Nature Biotechnology. 42(10). 1515–1525. 39 indexed citations
4.
Benbarche, Salima, Bo Liu, Jeetayu Biswas, et al.. (2023). Synthetic Introns Identify the Novel RNA Splicing Factor GPATCH8 As Required for Mis-Splicing Induced By SF3B1 Mutations. Blood. 142(Supplement 1). 3–3. 1 indexed citations
5.
Tuckett, Andrea Z., et al.. (2018). Repurposing of the CDK inhibitor PHA-767491 as a NRF2 inhibitor drug candidate for cancer therapy via redox modulation. Investigational New Drugs. 36(4). 590–600. 24 indexed citations
6.
Mondal, Chandrani, Julie S. Di Martino, Toshimitsu Takagi, et al.. (2018). Distant Insulin Signaling Regulates Vertebrate Pigmentation through the Sheddase Bace2. Developmental Cell. 45(5). 580–594.e7. 12 indexed citations
7.
Pelossof, Raphael, Lauren Fairchild, Chun‐Hao Huang, et al.. (2017). Prediction of potent shRNAs with a sequential classification algorithm. Nature Biotechnology. 35(4). 350–353. 96 indexed citations
8.
Kim, Isabella S., Silja Heilmann, Emily R. Kansler, et al.. (2017). Microenvironment-derived factors driving metastatic plasticity in melanoma. Nature Communications. 8(1). 14343–14343. 105 indexed citations
9.
Brea, Elliott J., Claire Y. Oh, Eusebio Manchado, et al.. (2016). Kinase Regulation of Human MHC Class I Molecule Expression on Cancer Cells. Cancer Immunology Research. 4(11). 936–947. 128 indexed citations
10.
Fennell, Myles, et al.. (2015). High-Content, Full Genome siRNA Screen for Regulators of Oncogenic HRAS -Driven Macropinocytosis. Assay and Drug Development Technologies. 13(7). 347–355. 11 indexed citations
11.
Ben‐David, Uri, Tamar Golan‐Lev, Payal Arora, et al.. (2013). Selective Elimination of Human Pluripotent Stem Cells by an Oleate Synthesis Inhibitor Discovered in a High-Throughput Screen. Cell stem cell. 12(2). 167–179. 250 indexed citations
12.
Hoffman, Ann F. & Ralph Garippa. (2006). A Pharmaceutical Company User's Perspective on the Potential of High Content Screening in Drug Discovery. Humana Press eBooks. 356. 19–32. 22 indexed citations
13.
Garippa, Ralph, Ann F. Hoffman, Gabriele Gradl, & Achim K. Kirsch. (2006). High‐Throughput Confocal Microscopy for β‐Arrestin–Green Fluorescent Protein Translocation G Protein‐Coupled Receptor Assays Using the Evotec Opera. Methods in enzymology on CD-ROM/Methods in enzymology. 414. 99–120. 29 indexed citations
14.
Guertin, Kevin R., Lida Qi, R. Dunsdon, et al.. (2003). Identification of a novel class of orally active pyrimido[5,4-3][1,2,4]triazine-5,7-diamine-based hypoglycemic agents with protein tyrosine phosphatase inhibitory activity. Bioorganic & Medicinal Chemistry Letters. 13(17). 2895–2898. 36 indexed citations
15.
Garippa, Ralph, et al.. (1996). The Carboxyl Terminus of GLUT4 Contains a Serine-Leucine-Leucine Sequence That Functions as a Potent Internalization Motif in Chinese Hamster Ovary Cells. Journal of Biological Chemistry. 271(34). 20660–20668. 54 indexed citations
16.
Bolin, David, et al.. (1995). Structure‐activity studies on the vasoactive intestinal peptide pharmacophore. International journal of peptide & protein research. 46(3-4). 279–289. 8 indexed citations
17.
O’Donnell, Mike, Ralph Garippa, William M. Selig, et al.. (1994). Ro 25-1553: a novel, long-acting vasoactive intestinal peptide agonist. Part II: Effect on in vitro and in vivo models of pulmonary anaphylaxis.. Journal of Pharmacology and Experimental Therapeutics. 270(3). 1289–1294. 46 indexed citations
18.
Bolin, David, et al.. (1993). Structure‐activity studies of vasoactive intestinal peptide (VIP): cyclic disulfide analogs. International journal of peptide & protein research. 41(2). 124–132. 16 indexed citations
19.
Bolin, David, et al.. (1992). Degradation of vasoactive intestinal peptide in bronchial alveolar lavage fluid. Biomedical Research-tokyo. 13. 25–30. 6 indexed citations
20.
O’Donnell, Mike, et al.. (1987). Pharmacological profile of Ro 23-3544, a new aerosol active leukotriene receptor antagonist.. PubMed. 17A. 512–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Claus Liebmann Breakdown of academic impact, for papers by Randall P. French Breakdown of academic impact, for papers by Xiu-Rong Ren Breakdown of academic impact, for papers by Juan Manuel García‐Martínez Breakdown of academic impact, for papers by Patrick E. Burnett Breakdown of academic impact, for papers by Luisella Toschi Breakdown of academic impact, for papers by Raymond K. Tong Breakdown of academic impact, for papers by Tara J. Dillon Breakdown of academic impact, for papers by Maria Kontogiannea Breakdown of academic impact, for papers by Christopher G. Armstrong
Rankless by CCL
2026